Cordio Medical
HealthTech & Life SciencesCordio Medical develops technology that analyses speech samples recorded through a smartphone application.
Introduce me to Cordio Medical
Image source: company website sharing image
Founders & company facts
Sources reviewed:Reported cumulative funding
$21,200,000 · Source
This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .
Documented founding team
- Aviv LotanSource: Aviv Lotan
- Chaim LotanSource: Chaim Lotan
- Shelly LotanSource: Shelly Lotan
Company overview
Product & customers
Cordio Medical develops technology that analyses speech samples recorded through a smartphone application. Its HearO programme focuses on monitoring changes associated with heart-failure deterioration for clinical follow-up.
Commercial potential · editorial analysis
The commercial opportunity is supporting remote follow-up through a familiar daily interaction instead of requiring patients to manage additional sensing hardware. Investors should distinguish paid use and renewals from pilots, and examine how sales and delivery costs change as deployments expand.
What to validate
Diligence should focus on prospective clinical evidence, language and voice variability, false alerts, patient adherence and escalation protocols. Evidence should come from representative customer deployments, with costs, limitations and failure cases reported alongside successful results.
Product source reviewed on . Company source